Form 4: DURECT Director Exercises Stock Options Under 10b5-1 Plan

DURECT Corporation Director Gail M. Farfel exercised 5,500 stock options at $1.22 per share, increasing her direct beneficial ownership as part of a pre-planned transaction.

Summary

• Gail M. Farfel, a Director of DURECT Corporation (DRRX), reported a transaction involving the exercise of stock options.
• On September 10, 2025, Ms. Farfel exercised 5,500 stock options at an exercise price of $1.22 per share.
• This transaction was conducted pursuant to a Rule 10b5-1(c) pre-planned contract, instruction, or written plan.
• Following the exercise, Ms. Farfel directly beneficially owns 15,500 shares of Common Stock.
• The exercised stock options had an expiration date of September 25, 2034.
• The options vest 100% on the day before the first anniversary of the grant date, contingent on Ms. Farfel's continued service to the company.

Sentiment

Score: 6

Explanation: The exercise of stock options by a director, especially under a pre-planned 10b5-1 arrangement, is a routine event. While it increases insider ownership, which can be a positive signal, it is not typically a strong indicator of significant future performance or a major market-moving event.

Positives

• A director exercising stock options increases their direct ownership in the company, which can signal confidence in the company's future performance.
• The transaction was pre-planned under a Rule 10b5-1(c) plan, indicating a structured approach to insider trading compliance.

Future Outlook

The stock options are subject to a vesting schedule where 100% of the shares will vest and become exercisable on the day before the first anniversary of the grant date, provided the reporting person continues to provide services to the company through the vesting date.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction and does not directly provide insights into broader industry trends. It reflects an individual director's equity activity within DURECT Corporation.

Stakeholder Impact

• Shareholders may view the director's increased ownership as a minor positive signal of alignment with shareholder interests, though the transaction is pre-planned and not discretionary.

Next Steps

• Continued service by Gail M. Farfel to DURECT Corporation is required for the full vesting of the option grant.

Key Dates

Recommendation

A director's exercise of stock options, particularly when pre-planned under a 10b5-1 plan, is a routine insider transaction. It typically does not provide sufficient new information to warrant a change in investment recommendation for DURECT Corporation. While it indicates continued participation, it is not a strong signal for significant price movement on its own.

Keywords

DURECT Corporation, DRRX, Gail M. Farfel, Stock Option Exercise, Insider Transaction, Form 4, Director Stock Ownership, 10b5-1 Plan